New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- New study targets Achilles' heel of pancreatic cancer, with promising results on April 17, 2019 at 10:02 am
Advanced pancreatic cancer is often symptomless, leading to late diagnosis only after metastases have spread throughout the body. Additionally, tumor cells are encased in a "protective shield," a ... […]
- FDA Expands Approval for Companion Diagnostic for Keytruda in Non-Small Cell Lung Cancer on April 17, 2019 at 8:26 am
The Food and Drug Administration (FDA) expanded the approval of the first and only companion diagnostic to Keytruda (pembrolizumab) in non-small cell lung cancer (NSCLC), the PD-L1 IHC 22C3 pharmDx ... […]
- Companion Diagnostics Market: Growing Prevalence of Cancer Sustaining Strong Demand on April 17, 2019 at 8:14 am
Apr 17, 2019 (AB Digital via COMTEX) -- Companion Diagnostics Market Outlook Prevalence of an infectious disease is a burden for the citizen’s economic and healthy growth across the globe. ... […]
- Global Cervical Cancer Diagnostics & Therapeutics Market Forecasts to 2024 - ResearchAndMarkets.com on April 17, 2019 at 7:55 am
DUBLIN--(BUSINESS WIRE)--Apr 17, 2019--The "Cervical Cancer Diagnostics and Therapeutics Market - Growth, Trends, and Forecast (2019 - 2024)" report has been added to ResearchAndMarkets.com's offering ... […]
- LL Cool J wanted to give wife fibula bone following cancer diagnosis on April 17, 2019 at 7:00 am
LL Cool J wanted to give his wife his fibula bone when she was diagnosed with cancer. The 51-year-old rapper - who's real name is James Todd Smith - has opened up about his wife, Simon Smith's, battle ... […]
- After a cancer diagnosis at 30 'shook her world' this P.E.I. woman wants to spread hope on April 16, 2019 at 4:18 pm
P.E.I. native Michelle Fuller was first diagnosed with cancer in 1999 at the age of 30, when she had surgery to remove her right eye, her cheekbone and part of the roof of her mouth. Fuller has had ... […]
- Alternative therapies for cancer: Do they do more harm than good? on April 16, 2019 at 11:10 am
In 2018, the National Cancer Institute estimated that 1,735,350 people in the United States would receive a diagnosis of cancer by the end of that year and that 609,640 people would die from the ... […]
- Ensuring an Accurate Lung Cancer Diagnosis Up Front on April 16, 2019 at 10:11 am
A discussion on the importance of obtaining a second opinion for any lung cancer diagnosis, whether at a cancer center of excellence, or at a community hospital. Phillippa J. Cheetham, M.D.: Lots of ... […]
- My Son’s Cancer Diagnosis Made Me A Stronger Mom on April 16, 2019 at 8:25 am
I am grateful for my son's cancer diagnosis. Say whaa? I know. If I hold up a mirror right now, I am giving myself the sarcastic stink eye as well. In the words of a dear friend: “Please don’t hear ... […]
via Bing News